The primary objective is to evaluate the impact of Pharmaceutical Interviews in the patient self-management of non-severe side effects caused by antibiotics prescribed for the treatment of osteoarticular infections when the patient returns home.

Inclusion Criteria:

• Patient > or =18 years;
• Informed consent signed;
• French-speaking and reading;
• Affiliated to a social insurance;
• Benefiting from medical and surgical care for an osteoarticular infection;
• Treated with an oral antibiotic therapy on discharge from hospital.
• Indication of the antibiotic therapy osteoarticular infection;
• Return home immediately after discharge.

Exclusion Criteria:

• Refusal to participate
• Protected adult patient, under guardianship or curatorship.
• Minor patient
• Patient benefiting from an AME.
• Pregnant or breastfeeding woman.
• Non-French speaking patient.
• Patient unable to understand the course of the study.
• Patient with a documented history of cognitive or psychiatric disorders.
• Patient treated with oral antibiotic therapy for an indication other than osteoarticular infection.
• Patient treated with parenteral antibiotic therapy.
• Discharge: Institution (EHPAD), rehabilitation or other health establishment.
• Patient systematically using one of the symptomatic treatments proposed in the discharge prescription before hospitalization.